We are live on ! Find out more
NI

Nepsis Inc Portfolio holdings

AUM $295M
1-Year Est. Return 35.44%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+35.44%
3 Year Est. Return
+115.51%
5 Year Est. Return
+196.69%
10 Year Est. Return
+848.99%
AUM
$316M
AUM Growth
+$40.7M
Cap. Flow
+$18.1M
Cap. Flow %
5.73%
Top 10 Hldgs %
52.66%
Holding
32
New
Increased
22
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
RNR icon
RenaissanceRe
RNR
+$7.36M
2
CVS icon
CVS Health
CVS
+$3.76M
3
V icon
Visa
V
+$3.23M
4
AIG icon
American International
AIG
+$3.22M
5
MA icon
Mastercard
MA
+$3.07M

Top Sells

Rank Stock Value
1
NTNX icon
Nutanix
NTNX
+$6.46M
2
FLGT icon
Fulgent Genetics
FLGT
+$6.26M
3
BIDU icon
Baidu
BIDU
+$4.14M
4
FUBO icon
FuboTV Inc
FUBO
+$3.51M
5
DVN icon
Devon Energy
DVN
+$1.27M

Sector Composition

Rank Sector Weight
1 Financials 40.82%
2 Healthcare 19.32%
3 Technology 11.73%
4 Consumer Discretionary 9.39%
5 Communication Services 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPST icon
26
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$2.65M 0.84%
52,164
-860
-2% -$43.7K
SO icon
27
Southern Company
SO
$109B
$1.76M 0.56%
28,399
+1,171
+4% +$70.1K
GIS icon
28
General Mills
GIS
$19.1B
$1.62M 0.51%
26,460
-5,237
-17% -$302K
DUK icon
29
Duke Energy
DUK
$97.8B
$1.48M 0.47%
15,311
+568
+4% +$51.8K
GSK icon
30
GSK
GSK
$104B
$817K 0.26%
18,314
+1,025
+6% +$46.5K
NLY icon
31
Annaly Capital Management
NLY
$17.1B
-10,203
Closed -$345K
NTNX icon
32
Nutanix
NTNX
$16B
-202,620
Closed -$6.46M

Similar funds

Nepsis Inc's Q1 2021 Portfolio in Review

As of Q1 2021, Nepsis Inc held 32 positions worth $316M, up 15% from $275M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Nepsis Inc deployed $18.1M of net new capital in Q1 2021, adding to 22 existing holdings.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 36% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Fulgent Genetics, an estimated $6.26M trimmed.

  • Nepsis Inc added most to RenaissanceRe in Q1 2021, an estimated $7.36M increase.
  • Nepsis Inc's biggest Q1 2021 reduction was Fulgent Genetics, cutting an estimated $6.26M.
  • Nepsis Inc fully exited Nutanix in Q1 2021, selling an estimated $6.46M.
  • Nepsis Inc's ten largest holdings make up 53% of its $316M portfolio in Q1 2021.
  • Nepsis Inc opened 0 new positions and closed 2 in Q1 2021.
  • Nepsis Inc's portfolio value rose 15% quarter-over-quarter to $316M.

Based on Nepsis Inc's 13F filing for Q1 2021, filed 20 Apr 2021.